In 2023, Iceland and Estonia led the global antiinfective medicine sales with respective values of $95.7 and $93.4 per capita, showing year-on-year growth rates of 6.55% and 7.22%. Other significant markets include Belgium and Italy, with values of $81.1 and $71.9, and growth rates of 2.15% and 0.28% respectively. South Korea and the United Kingdom also demonstrated modest increases of 0.26% and 2.67%. In contrast, countries like Portugal, Mexico, and New Zealand experienced declines, with New Zealand having the steepest drop at -9.88%.
Future trends to watch include the impact of emerging healthcare technologies and policy changes on global antiinfective medicine sales. Particular attention should be paid to markets with declining sales, such as New Zealand, to understand underlying causes and potential recovery strategies. Innovations in antiinfective treatments and shifts in healthcare spending will also be pivotal factors influencing future sales dynamics.
Top countries in Antiinfective Medicine Sales by Country
| # | 10 Countries | US Dollars PPP Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Iceland | 95.7 | 2023 | +1.81% | +6.55% | View data |
| 2 | 2 Estonia | 93.4 | 2023 | +17.19% | +7.22% | View data |
| 3 | 3 Belgium | 81.1 | 2023 | -0.73% | +2.15% | View data |
| 4 | 4 Italy | 71.9 | 2023 | +0.7% | +0.28% | View data |
| 5 | 5 South Korea | 69.7 | 2023 | +0.14% | +0.26% | View data |
| 6 | 6 United Kingdom | 66.4 | 2023 | +2.47% | +2.67% | View data |
| 7 | 7 Spain | 65.5 | 2023 | +3.97% | +0.72% | View data |
| 8 | 8 Switzerland | 57.1 | 2023 | +1.78% | +0.72% | View data |
| 9 | 9 Denmark | 53.6 | 2023 | +1.52% | +1.73% | View data |
| 10 | 10 Slovakia | 48.3 | 2023 | +1.68% | +3.43% | View data |
